Tag: Deucravacitinib

Affecting millions of adults, psoriasis is a chronic inflammatory skin condition. In many cases, it manifests as moderate to severe plaque psoriasis, a condition now treated effectively with the oral medication Deucravacitinib.

For patients with moderate to severe psoriasis, oral medications offer a convenient alternative to injectables or topicals, working systemically to address the underlying inflammation. Determining the safest oral medication for psoriasis, however, is a complex consideration that depends on a patient's individual health status, disease severity, and specific risks.